-transparent.png){kind=logo}
We describe the production of marmoset lymphoblastoid cell interferon (IFN). Optimal yields of IFN were obtained when EBV-transformed lymphoblastoid cell lines (LCL) at a cell density of 1 X 10(6)/ml were incubated with 100 HAU Sendai virus/ml for 24 h. Sendai-virus-induced marmoset lymphoblastoid cell IFN was acid-stable and exerted antiviral activity on both homologous and heterologous human cells, thus allowing its classification as IFN alpha. Marmoset lymphoblastoid cell IFN did not inhibit the growth of herpesvirus-transformed marmoset T-or B-cell lines, but markedly enhanced marmoset NK-cell activity against human myeloid leukemia target cells. The use of lymphoblastoid cell IFN in marmosets in vivo may contribute to an understanding of the pathogenic role of IFN in herpesvirus-induced lymphoproliferative diseases.
J Abb, and
H Abb, and
F Deinhardt
June 1982,
Biken journal,
J Abb, and
H Abb, and
F Deinhardt
January 1975,
Journal of clinical microbiology,
J Abb, and
H Abb, and
F Deinhardt
January 1981,
Methods in enzymology,
J Abb, and
H Abb, and
F Deinhardt
December 1980,
Cancer treatment reviews,
J Abb, and
H Abb, and
F Deinhardt
January 1982,
Comptes rendus des seances de la Societe de biologie et de ses filiales,
J Abb, and
H Abb, and
F Deinhardt
July 1974,
Journal of the National Cancer Institute,
J Abb, and
H Abb, and
F Deinhardt
January 1981,
Acta microbiologica Academiae Scientiarum Hungaricae,
J Abb, and
H Abb, and
F Deinhardt
January 1980,
Developments in biological standardization,
J Abb, and
H Abb, and
F Deinhardt
January 1978,
Journal of clinical microbiology,
J Abb, and
H Abb, and
F Deinhardt
October 1977,
The Journal of biological chemistry,
